Citation Impact

Citing Papers

Sex Differences in the Cardiovascular Consequences of Diabetes Mellitus
2015
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
2022 Standout
Network medicine analysis of COPD multimorbidities
2014
DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants
2016 Standout
Genetic Susceptibility
2013
Fracture healing: mechanisms and interventions
2014 Standout
Osteoporosis
2019 Standout
Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome
2009
Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences
2017
The Effect of Atorvastatin in Patients with Polycystic Ovary Syndrome: A Randomized Double-Blind Placebo-Controlled Study
2008
Circulating Sclerostin in Disorders of Parathyroid Gland Function
2011
Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis
2011
Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study
2019 Standout
Polycystic Ovarian Syndrome: An Evidence-based Approach to Evaluation and Management of Diabetes and Cardiovascular Risks for Today??s Clinician
2007
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Cancer-associated cachexia
2018 Standout
WNT signaling in bone homeostasis and disease: from human mutations to treatments
2013 Standout
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Tuberculosis and lung damage: from epidemiology to pathophysiology
2018 StandoutNobel
IL-6 in Inflammation, Immunity, and Disease
2014 Standout
The Epidemiology of Pancreatitis and Pancreatic Cancer
2013 Standout
Clinical effects of Helicobacter pylori outside the stomach
2013
Searching for polycystic ovary syndrome in postmenopausal women
2007
Global aetiology and epidemiology of type 2 diabetes mellitus and its complications
2017 Standout
Evolving cancer–niche interactions and therapeutic targets during bone metastasis
2021
The Etiology of Acute Recurrent Pancreatitis in Children
2011
Treatment of PCOS in adolescence
2006
Role of Activin A and Myostatin in Human Cancer Cachexia
2015
Sclerostin: how human mutations have helped reveal a new target for the treatment of osteoporosis
2013 StandoutNobel
Comparative Effect of Zoledronic Acid Versus Denosumab on Serum Sclerostin and Dickkopf-1 Levels of Naive Postmenopausal Women With Low Bone Mass: A Randomized, Head-to-Head Clinical Trial
2013
Polycystic Ovary Syndrome
2005 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
The Role of the Reactive Oxygen Species and Oxidative Stress in the Pathomechanism of the Age‐Related Ocular Diseases and Other Pathologies of the Anterior and Posterior Eye Segments in Adults
2016 Standout
Circulating levels of dickkopf-1, osteoprotegerin and sclerostin are higher in old compared with young men and women and positively associated with whole-body bone mineral density in older adults
2017
The Metabolic Syndrome in Polycystic Ovary Syndrome
2007
Cardiovascular Risk Factors in Healthy Women with Previous Gestational Hypertension
2006
Polycystic ovary syndrome
1997
Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
2011 Standout
Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria
2008
Improvement in Endothelial Structure and Function after Metformin Treatment in Young Normal-Weight Women with Polycystic Ovary Syndrome: Results of a 6-Month Study
2005
Emerging therapeutic concepts for muscle and bone preservation/building
2015
Polycystic ovary syndrome
2016 Standout
Association between TNF-α -308 G/A polymorphism and COPD susceptibility: a meta-analysis update
2016
Hyperandrogenemia influences the prevalence of the metabolic syndrome abnormalities in adolescents with the polycystic ovary syndrome
2009
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
2015 Standout
Neutralisation of Dkk-1 protects from systemic bone loss during inflammation and reduces sclerostin expression
2010
Role of fibroblast growth factor 2 and wnt signaling in anabolic effects of parathyroid hormone on bone formation
2012
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Patients with sclerosteosis and disease carriers: Human models of the effect of sclerostin on bone turnover
2011
Circulating Activin A predicts survival in cancer patients
2017
Sclerostin and Dickkopf-1 as Therapeutic Targets in Bone Diseases
2012
Health Consequences of Obesity in Youth: Childhood Predictors of Adult Disease
1998 Standout
Genome-wide expression profile of human trabecular meshwork cultured cells, nonglaucomatous and primary open angle glaucoma tissue.
2006
Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases
2015 Standout
Iron-Deficiency Anemia
2015 Standout
Polycystic ovary syndrome as a developmental disorder
2008
Mechanistic Pathways of Sex Differences in Cardiovascular Disease
2016
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Dysbiosis Contributes to Arthritis Development via Activation of Autoreactive T Cells in the Intestine
2016 StandoutNobel
Adrenal hyperandrogenism does not deteriorate insulin resistance and lipid profile in women with PCOS
2017
Copper-related diseases: From chemistry to molecular pathology
2009

Works of Αθανάσιος Παπαθεοδώρου being referenced

Parathyroid hormone changes following denosumab treatment in postmenopausal osteoporosis
2013
The effect of teriparatide on serum Dickkopf‐1 levels in postmenopausal women with established osteoporosis
2009
Helicobacter pylori infection in patients with nonalcoholic fatty liver disease
2012
Circulating activin-A is elevated in patients with advanced multiple myeloma and correlates with extensive bone involvement and inferior survival; no alterations post-lenalidomide and dexamethasone therapy
2012
Association of Hyperandrogenemic and Metabolic Phenotype with Carotid Intima-Media Thickness in Young Women with Polycystic Ovary Syndrome
2005
Genotype–phenotype correlations for a wide spectrum of mutations in the Wilson disease gene (ATP7B)
2004
Development of novel microarray methodology for the study of mutations in the SERPINA1 and ADRB2 genes—Their association with Obstructive Pulmonary Disease and Disseminated Bronchiectasis in Greek patients
2009
The Effect of Zoledronic Acid on Serum Dickkopf-1, Osteoprotegerin, and RANKL in Patients with Paget's Disease of Bone
2009
Serum Dickkopf-1 is increased and correlates with reduced bone mineral density in patients with thalassemia-induced osteoporosis. Reduction post-zoledronic acid administration
2009
Development of a novel microarray methodology for the study of SNPs in the promoter region of the TNF-α gene—Their association with obstructive pulmonary disease in Greek patients
2007
Contribution of the CFTR gene, the pancreatic secretory trypsin inhibitor gene (SPINK1) and the cationic trypsinogen gene (PRSS1) to the etiology of recurrent pancreatitis
2007
Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women—the six-month effect of risedronate and teriparatide
2011
Serum Dickkopf-1 is increased and correlates with reduced bone mineral density in patients with thalassemia-induced osteoporosis. Reduction post-zoledronic acid administration
2009
Early effects of IL-6 receptor inhibition on bone homeostasis: a pilot study in women with rheumatoid arthritis.
2012
Rankless by CCL
2026